2-(3-Methoxyphenyl)-1h-1,3-benzodiazole, 95+%, 100mg

4-Amino-3-nitrobenzenesulfonamide, 95.0%, 25g

5-Bromo-2-methylbenzamide, 95+%, 100mg

1',4'-dihydro-3'H-spiro[piperidine-4,2'-quinoxalin]-3'-one hydrochloride, 95.0%, 5g

11-(2-(4-Methylpiperazin-1-yl)acetyl)-5,11-dihydro-6H-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one dihydrochloride, 99+%, 250mg

6-bromo-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95%, 100mg

Cinchocaine, 95.0%, 1g

2-Chloro-p-xylene>98.0%(GC)25g

(2R,3S,4R,5R)-2-(BENZYLOXY)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL, 95.0%, 1g

Unité de filtration avec membrane SFCA Taille des pores 0,45 μm, 500 ml, 500 ml, 90 mm, 12 pièce(s)

3-Chloro-2-nitrobenzaldehyde, 95.0%, 1g

tert-Butyl 3-(chloromethyl)azetidine-1-carboxylate, 95+%, 250mg

Ethyl 3-iodocyclobutanecarboxylate, 97%, 1g